Black Rock Inc. Applied Genetic Technologies Corp Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.89 $1,613 - $4,951	-5,564 Reduced 0.6%	918,381 $249,000
Q2 2022 Aug 12, 2022	SELL	$0.62 - $1.1 $120,515 - $213,818	-194,380 Reduced 17.38%	923,945 $711,000
Q1 2022 May 12, 2022	BUY	$1.07 - $2.71 $13,241 - $33,536	12,375 Added 1.12%	1,118,325 $1.2 Million
Q4 2021 Feb 10, 2022	BUY	$1.87 - $2.91 $124,861 - $194,303	66,771 Added 6.43%	1,105,950 $2.1 Million
Q3 2021 Nov 09, 2021	BUY	$3.01 - $4.12 $7,245 - $9,916	2,407 Added 0.23%	1,039,179 $3.13 Million
Q2 2021 Aug 11, 2021	BUY	$3.62 - $5.23 $3.75 Million - $5.42 Million	1,036,772 New	1,036,772 $4.05 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.